Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.760
+0.050 (1.06%)
At close: Oct 9, 2026, 4:00 PM EDT
4.770
+0.010 (0.21%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $104.17 million as of October 9, 2026. It is the 25,164th most valuable company in the world and the 4,098th biggest in the United States. Its market cap has decreased by 71.97% in one year.
Market Cap
104.17M
Enterprise Value
30.98M
1-Year Change
-71.97%
Global Rank
Country Rank
#4,098 United States
Category
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $104.17M, a decrease of -69.55%. That is a compound annual growth rate of -51.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 104.17M | -63.55% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 109.72M |
| Milestone Pharmaceuticals | 107.80M |
| Tenax Therapeutics | 107.12M |
| Tevogen | 106.69M |
| Black Diamond Therapeutics | 105.14M |
| Corbus Pharmaceuticals Holdings | 104.06M |
| PolyPid | 102.98M |
| Biomea Fusion | 102.93M |